Evidence map›Paper›PMID 36743413›Full record

ArticleFrontiers in cell and developmental biology2023

Systemic inflammatory regulators and risk of acute-on-chronic liver failure: A bidirectional mendelian-randomization study.

Shengnan Wang, Hao Zhu, Lin Pan, Mengyuan Zhang, Xiaoqiang Wan, Hongqin Xu, Rui Hua, Mingqin Zhu, Pujun Gao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
15.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Multifaceted mechanistic exploration ofFrontiers in cell and developmental biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. [Two-sample Mendelian randomization analysis for the causal relationship between 91 circulating inflammatory proteins and liver cirrhosis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shengnan WangDepartment of Neurology, The First Hospital of Jilin University, Changchun, China.
Hao ZhuDepartment of Hepatology, The First Hospital of Jilin University, Changchun, China.
Lin PanClinical College, Jilin University, Changchun, China.
Mengyuan ZhangDepartment of Respiratory, The First Hospital of Jilin University, Changchun, China.
Xiaoqiang WanDepartment of Interventional Radiology, The First Hospital of Jilin University, Changchun, China.
Hongqin XuDepartment of Hepatology, The First Hospital of Jilin University, Changchun, China.
Rui HuaDepartment of Hepatology, The First Hospital of Jilin University, Changchun, China.
Mingqin ZhuDepartment of Neurology, The First Hospital of Jilin University, Changchun, China.
Pujun GaoDepartment of Hepatology, The First Hospital of Jilin University, Changchun, China.
First Hospital of Jilin University · CNJilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation plays a role in the pathogenesis of acute-on-chronic liver failure (ACLF), however, whether there is a causal relationship between inflammation and ACLF remains unclear. A two-sample Mendelian randomization (MR) approach was used to investigate the causal relationship between systemic inflammatory regulators and ACLF. The study analyzed 41 cytokines and growth factors from 8,293 individuals extracted from a genome-wide association study (GWAS) meta-analysis database involving 253 ACLF cases and 456,095 controls. Our results showed that lower stem cell factor (SCF) levels, lower basic fibroblast growth factor (bFGF) levels and higher Interleukin-13 (IL-13) levels were associated with an increased risk of ACLF (OR = 0.486, 95% CI = 0.264-0.892,

Indexed as

acute-on-chronic liver failurecytokinesIL-13inflammationmendelian randomization

Identifiers

PMID36743413
PMCPMC9892464
OpenAlexW4317387922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.